Global Duchenne Muscular Dystrophy Market Data Survey Report 2025
Summary
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Major Type
as follows:
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Major Application
Major Type
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- PTC Therapeutics
- Sarepta Therapeutics
- Bristol-Myers Squibb
- ITALFARMACO
- BioMarin
- Daiichi Sankyo
- Daiichi Sankyo
- Summit Therapeutics
- FibroGen
- NS Pharma
- Pfizer
- ReveraGen BioPharma
- Wave Life
- Genethon
- Santhera Pharmaceuticals
- Male
- Female
Major Type
as follows:
- Deflazacort
- Prednisone
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 PTC Therapeutics
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Sarepta Therapeutics
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Bristol-Myers Squibb
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 ITALFARMACO
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 BioMarin
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Daiichi Sankyo
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Daiichi Sankyo
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Summit Therapeutics
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 FibroGen
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 NS Pharma
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Pfizer
3.12 ReveraGen BioPharma
3.13 Wave Life
3.14 Genethon
3.15 Santhera Pharmaceuticals
4 MAJOR APPLICATION
4.1 Male
4.1.1 Overview
4.1.2 Male Market Size and Forecast
4.2 Female
4.2.1 Overview
4.2.2 Female Market Size and Forecast
5 MARKET BY TYPE
5.1 Deflazacort
5.1.1 Overview
5.1.2 Deflazacort Market Size and Forecast
5.2 Prednisone
5.2.1 Overview
5.2.2 Prednisone Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 PTC Therapeutics
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Sarepta Therapeutics
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Bristol-Myers Squibb
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 ITALFARMACO
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 BioMarin
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Daiichi Sankyo
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Daiichi Sankyo
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Summit Therapeutics
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 FibroGen
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 NS Pharma
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Pfizer
3.12 ReveraGen BioPharma
3.13 Wave Life
3.14 Genethon
3.15 Santhera Pharmaceuticals
4 MAJOR APPLICATION
4.1 Male
4.1.1 Overview
4.1.2 Male Market Size and Forecast
4.2 Female
4.2.1 Overview
4.2.2 Female Market Size and Forecast
5 MARKET BY TYPE
5.1 Deflazacort
5.1.1 Overview
5.1.2 Deflazacort Market Size and Forecast
5.2 Prednisone
5.2.1 Overview
5.2.2 Prednisone Market Size and Forecast
5.3 Others
5.3.1 Overview
5.3.2 Others Market Size and Forecast
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of PTC Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Sarepta Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of ITALFARMACO
Tab Sales Revenue, Volume, Price, Cost and Margin of BioMarin
Tab Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Tab Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Tab Sales Revenue, Volume, Price, Cost and Margin of Summit Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of FibroGen
Tab Sales Revenue, Volume, Price, Cost and Margin of NS Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of ReveraGen BioPharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Wave Life
Tab Sales Revenue, Volume, Price, Cost and Margin of Genethon
Tab Sales Revenue, Volume, Price, Cost and Margin of Santhera Pharmaceuticals
Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of PTC Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Sarepta Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of ITALFARMACO
Tab Sales Revenue, Volume, Price, Cost and Margin of BioMarin
Tab Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Tab Sales Revenue, Volume, Price, Cost and Margin of Daiichi Sankyo
Tab Sales Revenue, Volume, Price, Cost and Margin of Summit Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of FibroGen
Tab Sales Revenue, Volume, Price, Cost and Margin of NS Pharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of ReveraGen BioPharma
Tab Sales Revenue, Volume, Price, Cost and Margin of Wave Life
Tab Sales Revenue, Volume, Price, Cost and Margin of Genethon
Tab Sales Revenue, Volume, Price, Cost and Margin of Santhera Pharmaceuticals
LIST OF FIGURES
Fig Global Duchenne Muscular Dystrophy Market Size and CAGR 2011-2017 (Million USD)
Fig Global Duchenne Muscular Dystrophy Market Size and CAGR 2011-2017 (Volume)
Fig Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2018-2025 (Volume)
Fig Male Market Size and CAGR 2011-2017 (Million USD)
Fig Male Market Size and CAGR 2011-2017 (Volume)
Fig Male Market Forecast and CAGR 2018-2025 (Million USD)
Fig Male Market Forecast and CAGR 2018-2025 (Volume)
Fig Female Market Size and CAGR 2011-2017 (Million USD)
Fig Female Market Size and CAGR 2011-2017 (Volume)
Fig Female Market Forecast and CAGR 2018-2025 (Million USD)
Fig Female Market Forecast and CAGR 2018-2025 (Volume)
Fig Deflazacort Market Size and CAGR 2011-2017 (Million USD)
Fig Deflazacort Market Size and CAGR 2011-2017 (Volume)
Fig Deflazacort Market Forecast and CAGR 2018-2025 (Million USD)
Fig Deflazacort Market Forecast and CAGR 2018-2025 (Volume)
Fig Prednisone Market Size and CAGR 2011-2017 (Million USD)
Fig Prednisone Market Size and CAGR 2011-2017 (Volume)
Fig Prednisone Market Forecast and CAGR 2018-2025 (Million USD)
Fig Prednisone Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Duchenne Muscular Dystrophy Market Size and CAGR 2011-2017 (Million USD)
Fig Global Duchenne Muscular Dystrophy Market Size and CAGR 2011-2017 (Volume)
Fig Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Duchenne Muscular Dystrophy Market Forecast and CAGR 2018-2025 (Volume)
Fig Male Market Size and CAGR 2011-2017 (Million USD)
Fig Male Market Size and CAGR 2011-2017 (Volume)
Fig Male Market Forecast and CAGR 2018-2025 (Million USD)
Fig Male Market Forecast and CAGR 2018-2025 (Volume)
Fig Female Market Size and CAGR 2011-2017 (Million USD)
Fig Female Market Size and CAGR 2011-2017 (Volume)
Fig Female Market Forecast and CAGR 2018-2025 (Million USD)
Fig Female Market Forecast and CAGR 2018-2025 (Volume)
Fig Deflazacort Market Size and CAGR 2011-2017 (Million USD)
Fig Deflazacort Market Size and CAGR 2011-2017 (Volume)
Fig Deflazacort Market Forecast and CAGR 2018-2025 (Million USD)
Fig Deflazacort Market Forecast and CAGR 2018-2025 (Volume)
Fig Prednisone Market Size and CAGR 2011-2017 (Million USD)
Fig Prednisone Market Size and CAGR 2011-2017 (Volume)
Fig Prednisone Market Forecast and CAGR 2018-2025 (Million USD)
Fig Prednisone Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)